Članki z zahtevami za javni dostop - Roland R. GriffithsVeč o tem
Ni na voljo nikjer: 4
Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function
MW Johnson, PS Hendricks, FS Barrett, RR Griffiths
Pharmacology & therapeutics 197, 83-102, 2019
Zahteve: US National Institutes of Health
Substance abuse: caffeine use disorders
RR Griffiths, CJ Reissig
Psychiatry, 1019-1040, 2008
Zahteve: US National Institutes of Health
Substance use and addictive disorders: Caffeine
SE Meredith, RR Griffiths
Psychiatry, 1435-1457, 2015
Zahteve: US National Institutes of Health
Psychedelic agents for treatment-resistant depression
N Gukasyan, RR Griffiths
Managing Treatment-Resistant Depression, 221-235, 2022
Zahteve: US National Institutes of Health
Na voljo nekje: 97
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
RR Griffiths, MW Johnson, MA Carducci, A Umbricht, WA Richards, ...
Journal of psychopharmacology 30 (12), 1181-1197, 2016
Zahteve: US National Institutes of Health
Caffeinated energy drinks—a growing problem
CJ Reissig, EC Strain, RR Griffiths
Drug and alcohol dependence 99 (1-3), 1-10, 2009
Zahteve: US National Institutes of Health
Human hallucinogen research: guidelines for safety
MW Johnson, WA Richards, RR Griffiths
Journal of psychopharmacology 22 (6), 603-620, 2008
Zahteve: US National Institutes of Health
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano, ND Sepeda, MW Johnson, ...
JAMA psychiatry 78 (5), 481-489, 2021
Zahteve: US National Institutes of Health
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
RR Griffiths, WA Richards, MW Johnson, UD McCann, R Jesse
Journal of psychopharmacology 22 (6), 621-632, 2008
Zahteve: US National Institutes of Health
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
MW Johnson, A Garcia-Romeu, MP Cosimano, RR Griffiths
Journal of psychopharmacology 28 (11), 983-992, 2014
Zahteve: US National Institutes of Health
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
RR Griffiths, MW Johnson, WA Richards, BD Richards, U McCann, ...
Psychopharmacology 218, 649-665, 2011
Zahteve: US National Institutes of Health
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
KA MacLean, MW Johnson, RR Griffiths
Journal of psychopharmacology 25 (11), 1453-1461, 2011
Zahteve: US National Institutes of Health
Long-term follow-up of psilocybin-facilitated smoking cessation
MW Johnson, A Garcia-Romeu, RR Griffiths
The American journal of drug and alcohol abuse 43 (1), 55-60, 2017
Zahteve: US National Institutes of Health
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction
A Garcia-Romeu, R R. Griffiths, M W. Johnson
Current drug abuse reviews 7 (3), 157-164, 2014
Zahteve: US National Institutes of Health
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences
TM Carbonaro, MP Bradstreet, FS Barrett, KA MacLean, R Jesse, ...
Journal of psychopharmacology 30 (12), 1268-1278, 2016
Zahteve: US National Institutes of Health
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin
FS Barrett, MW Johnson, RR Griffiths
Journal of psychopharmacology 29 (11), 1182-1190, 2015
Zahteve: US National Institutes of Health
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and …
RR Griffiths, MW Johnson, WA Richards, BD Richards, R Jesse, ...
Journal of psychopharmacology 32 (1), 49-69, 2018
Zahteve: US National Institutes of Health
Factor analysis of the mystical experience questionnaire: A study of experiences occasioned by the hallucinogen psilocybin
KA MacLean, JMS Leoutsakos, MW Johnson, RR Griffiths
Journal for the scientific study of religion 51 (4), 721-737, 2012
Zahteve: US National Institutes of Health
Potential therapeutic effects of psilocybin
MW Johnson, RR Griffiths
Neurotherapeutics 14, 734-740, 2017
Zahteve: US National Institutes of Health
Energy drink consumption and increased risk for alcohol dependence
AM Arria, KM Caldeira, SJ Kasperski, KB Vincent, RR Griffiths, ...
Alcoholism: Clinical and Experimental Research 35 (2), 365-375, 2011
Zahteve: US National Institutes of Health
Podatke o objavi in financiranju samodejno določi računalniški program